Persisting yeast species and elicit unique airway inflammation in mice following repeated exposure.

BACKGROUND

Allergic airway disease (AAD) is a growing concern in industrialized nations and can be influenced by fungal exposures. Basidiomycota yeast species such as are known to exacerbate allergic airway disease; however, recent indoor assessments have identified other Basidiomycota yeasts, including (syn. ), to be prevalent and potentially associated with asthma. Until now, the murine pulmonary immune response to repeated exposure was previously unexplored.

OBJECTIVE

This study aimed to compare the immunological impact of repeated pulmonary exposure to yeasts.

METHODS

Mice were repeatedly exposed to an immunogenic dose of or oropharyngeal aspiration. Bronchoalveolar lavage fluid (BALF) and lungs were collected to examine airway remodeling, inflammation, mucous production, cellular influx, and cytokine responses at 1 day and 21 days post final exposure. The responses to and were analyzed and compared.

RESULTS

Following repeated exposure, both and cells were still detectable in the lungs 21 days post final exposure. Repeated exposure initiated myeloid and lymphoid cellular infiltration into the lung that worsened over time, as well as an IL-4 and IL-5 response compared to PBS-exposed controls. In contrast, repeated exposure induced a strong CD4 T cell-driven lymphoid response that started to resolve by 21 days post final exposure.

DISCUSSION

remained in the lungs and exacerbated the pulmonary immune responses as expected following repeated exposure. The persistence of in the lung and strong lymphoid response following repeated exposure were unexpected given its lack of reported involvement in AAD. Given the abundance in indoor environments and industrial utilization of , these results highlight the importance to investigate the impact of frequently detected fungal organisms on the pulmonary response following inhalational exposure. Moreover, it is important to continue to address the knowledge gap involving Basidiomycota yeasts and their impact on AAD.